Techniques in Vascular & Interventional Radiology
Volume 10, Issue 2 , Pages 132-139, June 2007

Radiofrequency Ablation of Renal Tumors

  • Michael J. Stone, MD

      Affiliations

    • Research Fellow, National Institutes of Health Clinical Center, Diagnostic Radiology Department, Bethesda, Md.
    • ,
  • Aradhana M. Venkatesan, MD

      Affiliations

    • Staff Clinician, National Institutes of Health Clinical Center, Diagnostic Radiology Department, Bethesda, MD.
    • ,
  • Julia Locklin, RN, MS, CCRC

      Affiliations

    • Research Nurse Specialist, National Institutes of Health Clinical Center, Diagnostic Radiology Department, Bethesda, MD.
    • ,
  • Peter Pinto, MD

      Affiliations

    • Urologic Oncology Branch, National Cancer Institute, Bethesda, MD.
    • ,
  • Marston Linehan, MD

      Affiliations

    • Urologic Oncology Branch, National Cancer Institute, Bethesda, MD.
    • ,
  • Bradford J. Wood, MD

      Affiliations

    • Chief, Interventional Radiology, Diagnostic Radiology Department, National Institutes of Health Clinical Center, Diagnostic Radiology Department, Bethesda, MD.
    • Corresponding Author InformationAddress reprint requests to: Bradford J. Wood, MD, Diagnostic Radiology Department, National Institutes of Health Clinical Center, 1N-264, Department of Diagnostic Radiology, 10 Center Drive MSC 1182, Bethesda, MD 20892.

Radiofrequency ablation (RFA) of renal tumors is a promising technique that plays a unique and increasingly important role in urologic oncology practices. RFA is appealing as a minimally invasive therapy that may be performed on an outpatient basis. It enables treatment of an area 3 to 5 cm in diameter, with relatively low morbidity and mortality rates. Most interventional radiologists (IRs) are familiar with RFA of liver tumors, and several principles and techniques used in the liver may be extrapolated for use in the kidney. However, it is crucial to bear in mind that local tumor ablation in the kidney presents unique challenges, secondary to the kidney’s unique anatomic and physiologic features. Clinical and technical considerations, risks, and complications pertaining to RFA of renal tumors are reviewed here, including approaches commonly used in our practice.

Keywords: radiofrequency ablation, kidney, renal cell carcinoma, Von Hippel-Lindau syndrome

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was supported in part by the Intramural Research Program of the National Institutes of Health.

PII: S1089-2516(07)00087-X

doi:10.1053/j.tvir.2007.09.011

Techniques in Vascular & Interventional Radiology
Volume 10, Issue 2 , Pages 132-139, June 2007

Article Tools

* Image Usage & Resolution